J. Goldman & Co’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-300,000
Closed -$2.96M 600
2021
Q1
$2.96M Buy
+300,000
New +$3.05M 0.1% 215

Other funds holding MSACU

J. Goldman & Co's MSACU Position: Q2 2021 in Review

J. Goldman & Co sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 300,000 shares — an estimated $2.96M sold.

J. Goldman & Co first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $2.96M in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • J. Goldman & Co reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • J. Goldman & Co sold 300,000 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $2.96M.
  • J. Goldman & Co first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • J. Goldman & Co's Medicus Sciences Acquisition Corp. Unit position peaked at $2.96M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on J. Goldman & Co's 13F filing for Q2 2021, filed 16 Aug 2021.